Atrasentan

Atrasentan
Trade Name
Orphan Indication Focal segmental glomerulosclerosis
USA Market Approval USA
USA Designation Date 2016-09-29 00:00:00
Sponsor AbbVie Inc.;Regulatory Affairs, 1 North Waukegan Road;North Chicago, Illinois, 60044